Tina Chen

Tina Chen is a seasoned Regulatory Affairs Professional with 20 years of experience in the pharmaceutical industry, specializing in CMC and drug development. Currently serving as the Global RA CMC lead at Sanofi, they have previously held significant roles at MSD and Bristol Myers Squibb, supporting regulatory strategies for a variety of drug submissions. Tina has a robust background that includes evaluating novel technologies at Merck and conducting biomedical research across various sectors, including oncology and biotechnology. They hold multiple certifications in regulatory affairs and project management, alongside advanced degrees in Biotechnology and Biochemistry.